These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4976177)

  • 1. [Symptomatic management of Chagas' heart disease using a beta-adrenergic blocking agent].
    Luquez HA; Madoery R; Amuchastegui SR; Patrignani JA
    Prensa Med Argent; 1968 Jun; 55(17):774-8. PubMed ID: 4976177
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental Chagas' disease: effects of propranolol upon cardiac beta-receptors.
    Fernández R; Enders J; Rivarola W; Palma J; Paglini P
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):93-8. PubMed ID: 9695881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta adrenergic blocking agents in Chagasic heart disease].
    Plotquin Y; Abrahim HC
    Prensa Med Argent; 1968 Oct; 55(35):1725-30. PubMed ID: 4977209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
    Vichi FL; Nobre F; Evora P; Ribeiro PJ; Papa MV
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():101-6. PubMed ID: 407891
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic Chagas' disease: possible mechanism of sinus bradycardia.
    Caeiro T; Iosa D
    Can J Cardiol; 1994 Sep; 10(7):765-8. PubMed ID: 7922833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiopathy in Americana trypanosomiasis (Chagas' disease)].
    Kireev PM
    Klin Med (Mosk); 1975 May; 52(5):34-7. PubMed ID: 805880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of propranolol, beta-adrenergic blocking agent, on disorders of cardiac rhythm].
    Sánchez A; Cárdenas M; Shapiro M
    Arch Inst Cardiol Mex; 1967; 37(1):47-62. PubMed ID: 6058090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Congestive-type primary myocardiopathies: treatment with beta-blocking agents].
    Ponsonnaille J; Pailloncy M; Goujon B; Marcheix JC; Gras H
    Nouv Presse Med; 1978 Feb; 7(7):570. PubMed ID: 643584
    [No Abstract]   [Full Text] [Related]  

  • 9. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on acute murine Chagas' disease.
    Tanowitz HB; Wittner M; Chen B; Huang H; Weiss LM; Christ GJ; Braunstein V; Bilezikian JP; Morris SA
    J Parasitol; 1996 Oct; 82(5):814-9. PubMed ID: 8885893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of propranolol in coronary insufficiency and in some cardiac arrhythmias].
    Zavala Jurado A; Gonzalez Martin A; De Feuillade ND; Liñan JM
    Prensa Med Argent; 1968 Aug; 55(26):1271-8. PubMed ID: 4974565
    [No Abstract]   [Full Text] [Related]  

  • 12. T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease.
    Salles GF; Xavier SS; Sousa AS; Hasslocher-Moreno A; Cardoso CR
    Am J Cardiol; 2004 May; 93(9):1136-40. PubMed ID: 15110206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas' heart disease in Europe: an emergent disease?
    Dobarro D; Gomez-Rubin C; Sanchez-Recalde A; Olias F; Bret-Zurita M; Cuesta-Lopez E; Robles-Marhuenda A; Fraile-Vicente JM; Paño-Pardo JR; Lopez-Sendon J
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1263-7. PubMed ID: 19001935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of angina pectoris with an adrenergic beta receptor blocking agent].
    Lamprecht G; Schmidt-Voigt J
    Med Klin; 1966 Jan; 61(1):18-22. PubMed ID: 5983153
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.
    Salles G; Xavier S; Sousa A; Hasslocher-Moreno A; Cardoso C
    Circulation; 2003 Jul; 108(3):305-12. PubMed ID: 12835217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicity and therapeutic value of Bay 2502 in chronic Chagas' disease in 3 dosage schemes].
    Cançado JR; Marra UD; Lopes M; Mourão O; Faria CA; Alvares JM; Salgado Ade A
    Bol Chil Parasitol; 1969; 24(1):28-32. PubMed ID: 4983547
    [No Abstract]   [Full Text] [Related]  

  • 17. Autonomic blockade in chronic Chagas' heart disease. Heart rate response at rest and during upright exercise. A preliminary report.
    Gallo L; Manço JC; Godoy RA; Amorim DS
    Arq Bras Cardiol; 1969 Oct; 22(5):207-14. PubMed ID: 4982837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic evaluation of 2,6 bis(diethanolamino)-4,8-dipiperidino-pyrimido(5,4-d) pyrimidine in patients with Chagas' heart disease].
    Montenegro CI; Kuschnir E; Corcoba C
    Prensa Med Argent; 1965 Jul; 52(27):1649-55. PubMed ID: 4955205
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for Chagas' disease reactivation after heart transplantation.
    Campos SV; Strabelli TM; Amato Neto V; Silva CP; Bacal F; Bocchi EA; Stolf NA
    J Heart Lung Transplant; 2008 Jun; 27(6):597-602. PubMed ID: 18503957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic experience with Bay 2502 in chronic Chagas' disease in adults. Importance of the correct use of xenodiagnosis].
    Schenone H; Concha L; Aranda R; Rojas A; Alfaro E
    Bol Chil Parasitol; 1969; 24(1):66-9. PubMed ID: 4983556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.